TapImmune Inc (TPIV) (TPIV.OB)
Health Care and BioMed Continue to Reap the Rewards!
Emerging Biomed companies are the place to be.
With the proper product and audience the returns can be out this world.
We would like to show you just such a company.
Currrent Value: $0.46
Shorrt Term Tarrget: $1.25
Lonng Term Tarrget: $4.30
TapImmune Inc. is a biotechnology company specializing
in the development of innovative cell based immunotherapeutics
and vaccines in the areas of cancer and infectious disease.
The Company's lead product candidate, the AdhTAP vaccine enhancer
is designed to restore and augment antigen presentation and subsequent
recognition and killing of cancer cells by the immune system.
The Company is also developing a TAP based prophylactic vaccine
which initial tests indicate may increase the efficacy of targeted prophylactic vaccines by up to 1000 times.
All eyes are going to be on this Winner with a Major Awareness campaign shifting into top gear.
Keep it on your radar!
In his first official act Benedict visited the mausoleum of Mustafa Kemal Ataturk the
founder of modern Turkey In a guest book he wrote that Turkey is a meeting point of different religions and cultures and a bridge between Asia and Europe
Later Tuesday while addressing Turkeys diplomatic corps the pope heralded the countrys
role in the UN peacekeeping force in southern Lebanon